Stig D Friis1, Troels Skrydstrup, Stephen L Buchwald. 1. Center for Insoluble Protein Structures (inSPIN), Interdisciplinary Nanoscience Center (iNANO) and Department of Chemistry, Aarhus University , Gustav Wieds Vej 14, 8000 Aarhus C, Denmark.
Abstract
A palladacyclic precatalyst is employed to cleanly generate a highly active XantPhos-ligated Pd-catalyst. Its use in low temperature aminocarbonylations of (hetero)aryl bromides provides access to a range of challenging products in good to excellent yields with low catalyst loading and only a slight excess of CO. Some products are unattainable by traditional carbonylative coupling.
A palladacyclic precatalyst is employed to cleanly generate a highly active XantPhos-ligated Pd-catalyst. Its use in low temperature aminocarbonylations of (hetero)aryl bromides provides access to a range of challenging products in good to excellent yields with low catalyst loading and only a slight excess of CO. Some products are unattainable by traditional carbonylative coupling.
Heterocycles are an important
constituent in many pharmaceuticals.[1] Transition
metal catalysis plays a key role in the selective functionalization
of heteroaromatic systems. Yet, many metal-catalyzed transformations
suffer from the metal coordinating ability of heterocycles, resulting
either in byproduct formation or inhibition of catalytic turnover.[2] In many instances, specialized reaction conditions
or catalyst systems are needed in order to provide reasonable yields
of the desired products.[3]Amides
represent a ubiquitous functional group in pharmaceutically
relevant compounds and are frequently attached to a heteroaryl core
(Figure 1). Although many routes rely on the
use of carboxylic acid starting materials,[4] an appealing approach to amides relies on a three-component Pd-catalyzed
coupling of a (hetero)aryl halide with an amine and CO.[5] While this transformation has been widely used,
limitations remain with substrates bearing sensitive functional groups,
as the coupling of (hetero)aryl bromides usually must be conducted
at elevated temperatures.[6] The more reactive
(hetero)aryl iodides can in some cases be utilized, but only a narrow
selection of such iodides are available due to their limited stability.[7] The literature also reveals a lack of good procedures
for the conversion of more difficult (hetero)aryl bromides, including
3-bromoindole, 3-bromopyridazine, 2-bromothiazole, or 2-bromobenzimidazole,
into the corresponding amides.
Figure 1
Selection of FDA-approved drugs containing
heteroaryl amides.
Selection of FDA-approved drugs containing
heteroaryl amides.Herein, we describe the
low temperature conversion of aryl and
heteroaryl bromides to their corresponding secondary and tertiary
amides enabled by the use of a palladacycle precatalyst. The increased
activity of the catalyst generated from this precatalyst provides
easy access to products, which are otherwise inaccessible via Pd-catalyzed
aminocarbonylation or provide low yields due to significant unproductive
side reactions such as SNAr or addition to/substitution
of other functional groups in the molecule.In recent years,
palladium precatalysts have received significant
attention because of their ability to selectively generate the ligated
Pd(0)-complex with only minimal coordinating byproducts.[8] The employment of these precatalysts, with their
ease of use, significantly enhances the catalytic activity, compared
to catalysts generated from, e.g., Pd(dba)2 or Pd(OAc)2.[9] We therefore envisioned that
a catalyst generated from the palladacycle precatalyst 1 (Figure 2) could provide the additional activity
needed, in order to carbonylate more difficult heteroaryl bromides,
as well as substrates susceptible to SNAr-type reactions.
The N-methyl-2-aminobiphenyl based precatalyst 1 was chosen over the simpler 2-aminobiphenyl based precatalyst
to eliminate the potential reaction of the carbazole byproduct, which
would cause reduced yields and possibly complicate purification of
the products.[8f]
Figure 2
Palladacycle precatalyst
and phosphine ligands examined for low
temperature aminocarbonylations.
Palladacycle precatalyst
and phosphine ligands examined for low
temperature aminocarbonylations.Applying our COware two-chamber system and a solid silacarboxylic
acid CO precursor, to avoid the handling of the toxic gas, we set
out to develop conditions for this transformation.[10] As illustrated in Table 1, the unactivated
aryl bromide 2 was selected for the optimization studies.
Poor catalyst stability was observed when starting with the precatalysts 1a–d bearing monodentate ligands or dccp
[1,3-bis(dicyclohexylphosphino)propane], and only trace conversion
of 2 was observed. With precatalyst 1e based
on the ligand dppf [1,1′-bis(diphenylphosphino)ferrocene],
conversion to product was observed, but in low yield. In contrast,
with the precatalyst based on XantPhos1f,[5d,11] full conversion of 2 was seen and amide 3a was isolated in a 92% yield, when the reaction was carried out at
a temperature of only 45 °C. Decreasing the temperature further
resulted in incomplete conversion of 2.
Table 1
Optimization of Low Temperature Aminocarbonylation
Employing a Palladacycle Precatalysta
entry
catalyst
solvent
base
yield of 3a [%]b
1
1a–d
dioxane
Cy2NMe
trace
2
1e
dioxane
Cy2NMe
16
3
1f
dioxane
Cy2NMe
99 (92)
4
1g
dioxane
Cy2NMe
0
5c
1f
dioxane
DBU
6
6
1f
dioxane
K2CO3
97
7
1f
dioxane
Et3N
99 (97)
8
1f
MeCN
Et3N
24
9
1f
PhMe
Et3N
trace
10
1f
CPME
Et3N
21
11d
1f
dioxane
Et3N
99 (93)
2 (0.25 mmol), 0.25
M.
GC yield, isolated yield
in parentheses.
Yield of 3b: 19%
2 (1.0 mmol), 1f (2 mol %), Et3N (2.0 mmol),
and morpholine (2.0
mmol) in dioxane (2.0 mL).
2 (0.25 mmol), 0.25
M.GC yield, isolated yield
in parentheses.Yield of 3b: 19%2 (1.0 mmol), 1f (2 mol %), Et3N (2.0 mmol),
and morpholine (2.0
mmol) in dioxane (2.0 mL).The nature of the base included in the reaction was also crucial.
Employing 1f with the stronger base DBU (Table 1, entry 5) reduced the yield of the desired product
significantly and instead provided the double carbonylated product 3b in a 19% GC yield.[12] Triethylamine
proved to be the ideal base and was chosen for further optimization
as it gave a slightly higher isolated yield and is easily removed
under vacuum (Table 1, entry 7); dioxane is
the solvent of choice (Table 1, entries 8–10).
Increasing the concentration to 0.50 M while lowering the catalyst
loading to 2.0 mol % with 2.0 equiv of nucleophile and base did not
significantly affect the isolated yield (Table 1, entry 11).With conditions for a low temperature aminocarbonylation
at hand
enabled by the use of 1f, we set out to probe the scope
of this protocol as shown in Scheme 1. The
excellent yields of 4a and 4b demonstrate
that electron-poor and electron-rich aryl bromides can undergo efficient
coupling using this catalytic system. Turning to the heteroaromatic
bromides, 5-bromoisoquinoline was first coupled to afford 4c in a 99% isolated yield. Having the bromide situated on a heteroaryl
ring did not affect the yield, as 4d was isolated in
98% yield, while 87% of the 2,6-difunctionalized pyridine 4e was realized. The presence of an additional nitrogen in the ring
was also inconsequential as 5-bromopyrimidine could be converted to 4g in 93% yield.[13]
Scheme 1
Low Temperature
Aminocarbonylation of (Hetero)Aryl Bromides with
Morpholine; Isolated Yields and Average of Two Runs, (Het)Ar–Br
(1.0 mmol), 0.50 M
Used as HCl salt, Et3N (3.0 mmol).
80 °C.
65 °C.
MePh2SiCO2H (1.0
mmol), KF (1.0 mmol).
2,4-Dibromothiazole
(0.5 mmol).
0.25 M.
Low Temperature
Aminocarbonylation of (Hetero)Aryl Bromides with
Morpholine; Isolated Yields and Average of Two Runs, (Het)Ar–Br
(1.0 mmol), 0.50 M
Used as HCl salt, Et3N (3.0 mmol).80 °C.65 °C.MePh2SiCO2H (1.0
mmol), KF (1.0 mmol).2,4-Dibromothiazole
(0.5 mmol).0.25 M.The indole ring system represents a privileged structure
in drug
discovery, and it is well-known that reaction of substrates in which
the nitrogen is unprotected can be problematic.[2b,3b,14] This tendency was also observed in this
transformation as the carbonylation of unprotected 5-bromoindole must
be conducted at 80 °C to provide 4h in a satisfactory
yield. On the other hand, the corresponding N-Boc
substrate was carbonylated to provide an excellent yield of 4i at 45 °C. While no observable conversion of 3-bromo-N-Boc-indole was seen at this temperature, at 80 °C
the desired heteroaryl amide 4j was produced in a 87%
isolated yield. The more activated N-Boc-3-bromoindazole
coupled well to afford a 79% yield of amide 4k.The aminocarbonylation of a bromopyridazine and a bromocinnoline
also proceeded efficiently, leading to products 4l and 4m in good yields, although a slightly higher reaction temperature
was necessary to realize a good yield of 4m, possibly
due to the presence of an ortho substituent in the
substrate. The allyl-protected 2-bromobenzimidazole also coupled nicely
at low temperature to give 4n in an 82% isolated yield.The use of bromothiazoles as substrates was next examined. In particular,
these substrates are susceptible to SNAr with the amine
nucleophile.[15] Subjecting 2-bromothiazole
to the optimized reaction conditions furnished an 86% yield of product 4o, with no observation of product arising from SNAr. Applying identical conditions on the 2,4-dibromothiazole resulted
in only a 73% yield of the desired product 4p. The slightly
lower yield was due to a second carbonylation at C4 with the slight
excess of CO. Nevertheless, the yield was improved to 85% by lowering
the amount of the silacarboxylic acid to 1.0 equiv, thereby preventing
the coupling at the more electron-rich 4-position. On the other hand,
employing 2.4 equiv of CO provided smoothly the difunctionalized thiazole 4q in excellent yield, emphasizing the importance of being
able to accurately control the quantity of CO utilized in the reaction.Three different thiophenes were tested, providing both amide 4r and 4s in excellent yields. However, when
moving the bromide to the more electron-rich C3-position, a slight
increase in temperature was required for the reaction to go to completion,
providing 4t in 96% yield. The products 4u and 4v both contain functional groups that allow for
easy postcoupling modification via SN2 substitution of
the primary alkyl chloride in 4u or acyl substitution
of the thioester displayed by 4v. These functional groups,
however, also make them sensitive substrates, which may not be tolerated
under traditional aminocarbonylation conditions at elevated temperatures.
However, applying this more active catalytic system at 45 °C
provided the desired products in good yield.Next, variations
of the amine nucleophile were examined in the
aminocarbonylation of 2-bromopyridine. Using a volatile, sterically
hindered primary amine, tert-butylamine, did not
have a profound effect on the efficiency of the reaction, as the product 5a was isolated in 77% yield (Scheme 2). On the other hand, coupling with the more sterically hindered
diisopropylamine proved to be slightly more sluggish, furnishing 55%
of the desired amide 5b at 65 °C. This increased
temperature was also necessary to achieve full conversion with tritylamine
as the nucleophile, giving 5c, which can easily be converted
into the primary amide.[16] 3-Chloropropylamine
is commercially available as the corresponding hydrochloride, possibly
due to potential polymerization or intramolecular cyclization. Additional
base was consequently added for its reaction, and after 16 h at 45
°C, product 5d could be isolated in a 92% yield,
with no signs of SN2 substitution on the alkyl chloride.
Scheme 2
Low Temperature Aminocarbonylation of 2-Bromopyridine and a Selection
of Amines; Isolated Yields and Average of Two Runs, 2-Bromopyridine
(1.0 mmol), 0.50 M
65 °C.
Et3N (4.0 mmol).
Used as HCl ammonium salt.
0.25 M.
RR′NH (1.2 mmol), Et3N (3.2 mmol).
Low Temperature Aminocarbonylation of 2-Bromopyridine and a Selection
of Amines; Isolated Yields and Average of Two Runs, 2-Bromopyridine
(1.0 mmol), 0.50 M
65 °C.Et3N (4.0 mmol).Used as HCl ammonium salt.0.25 M.RR′NH (1.2 mmol), Et3N (3.2 mmol).Amines carrying an additional nucleophile were also examined.
For
example, ethanolamine was used for the synthesis of 5e in 95% yield. The presence of a free phenol is also tolerated as
seen by the high yield formation of 5h. However, introducing
a free aniline did have a slightly detrimental effect as 5i could only be isolated in a 72% yield.In order to demonstrate
the superiority of the palladacycle precatalyst,
it was compared to a selection of traditional Pd(0) and Pd(II) sources
reported in the literature (Figure 3).[5e,17] The conversion of aryl bromide 2 into amide 3a was examined at six temperatures ranging from 30 to 80 °C,
applying either precatalyst 1f or Pd(OAc)2, Pd(dba)2, or Pd(COD)Cl2 in combination with
an equimolar amount of XantPhos. Whereas the traditional Pd sources
did not show any catalytic turnover at temperatures lower than 60
°C and produced synthetically useful yields only at 80 °C,
precatalyst 1f furnished amide 3a in good
yield at 40 °C, while providing the amide quantitatively at 50
°C, emphasizing that a more active catalyst for the aminocarbonylation
is generated from this palladacycle precatalyst.
Figure 3
Comparison of palladacycle
precatalyst 1f with traditional
Pd sources at different temperatures. GC yields, 2 (1.0
mmol), 0.50 M.
Comparison of palladacycle
precatalyst 1f with traditional
Pd sources at different temperatures. GC yields, 2 (1.0
mmol), 0.50 M.In conclusion, the use
of a palladacycle precatalyst has been shown
to have a significant rate-enhancing effect on the aminocarbonylation
relative to traditional catalytic systems. The low temperature at
which this carbonylative coupling is conducted provides access to
a range of products that are otherwise not easily accessible. An array
of electron-rich and electron-poor aryl and heteroaryl bromides has,
despite their sensitive nature, been coupled in good to excellent
yields. Moreover, both tertiary and secondary amides have been synthesized,
while formal access to primary amides has been shown using tritylamine
as the nucleophile. Due to the generality of the method and its ease
of use, it should see wide utilization in both academic and industrial,
particularly pharmaceutical, settings.
Authors: Joseph R Martinelli; Donald A Watson; Dominique M M Freckmann; Timothy E Barder; Stephen L Buchwald Journal: J Org Chem Date: 2008-08-23 Impact factor: 4.354
Authors: Jianbo Liu; Matthew F L Parker; Sinan Wang; Robert R Flavell; F Dean Toste; David M Wilson Journal: Chem Date: 2021-08-03 Impact factor: 25.832
Authors: Jui Thiang Brian Kueh; Nathan J Stanley; Russell J Hewitt; Laura M Woods; Lesley Larsen; Joanne C Harrison; David Rennison; Margaret A Brimble; Ivan A Sammut; David S Larsen Journal: Chem Sci Date: 2017-05-30 Impact factor: 9.825